DCCC supports interdisciplinary, national initiatives and networks within the field of cancer. The purpose is to establish an infrastructure for knowledge sharing, to strengthen national collaboration and to promote faster translation of research results into clinical practice. In addition, to improve the opportunities to attract external research funding.
Several DCCC supported networks host Nordic and international activities and welcome international collaborations.
| Name of initiatives | Description | |
|---|---|---|
|
Nordic Anal Cancer Network (NOAC) |
||
|
Improving quality of life and functional capacity in haematological cancer |
||
|
National interdisciplinary network for research in cancer immunotherapy (IMMUNONET) |
||
|
PARAT – PAlliating RAdioTherapy for lung cancer |
||
|
Pathology Symposium: Soft tissue tumors of the skin |
||
|
SUPE-R meeting: preparing and initiating a national randomized clinical experiment to improve follow-ups for patients with lung cancer |
||
|
Implementation of personalised medicine (PM) in patients with no standard therapy for recurrent and/or drug resistant cancer |
||
|
Biliary tract cancer: diagnosis, etiological factors, treatments, prognostic factors and prognosis: knowledge exchange in a national perspective |
||
|
Danish Haematological KFE network – establishing a national office for investigator initiated clinical studies |
||
|
Danish National network of sarcoma research |
||
|
Implementation of clinical directions for cancer associated thrombosis and life quality of the multimorbid patient with needs for anticoagulant therapy |
||
|
Clinic for late effects of cancer – national diffusion of nurse-managed initial therapy |
||
|
Preparation of a nationally initiated rehabilitation project for patients with brain tumors |
||
|
DCCC Onco-Cardiology network, DOC |
||
|
Workshop on target delineation for spinal SBRT |
||
|
Deep Inspiration Breath Hold – the first national DIBH workshop |
||
|
National network for establishing standardised bio informative and classification workflows, a joint variant database and joint data sharing |
||
|
Network for harmonising interpretation of somatic variants for treatment of patients with refractory cancer |
||
|
Evidence-based patient care for gynecological cancer surgery – simplification of data and involvement |
||
|
National collaboration on joint clinical experiments for testing Personalised Medicine for haematological cancer diseases |
||
|
MDT-conference – status and developing perspectives |
||
|
The DBCG RT Recon Trial: Delayed-immediate versus delayed breast reconstruction in early breast cancer patients treated with mastectomy and adjuvant loco-regional radiation therapy. A multicenter randomized clinical trial |
||
|
ECV Cancer Symposium |
||
|
Implementation of structured training programs and perioperative protocols for operable cardia cancer |
||
|
Interdisciplinary collaboration for developing a national strategy for selection of patients with low-grade glioma for photon- or proton therapy |
||
|
Who will benefit from intensified local treatment? – A failure prediction model for locally advanced non-small cell lung cancer |
||
|
DCCC shared decision making network (DCCC SDM) |
||
|
National Interdisciplinary Network for Quality Assurance of MR Images in Radiotherapy (NIMBUS) |
||
|
Collaboration between the palliative database/DMCG and the disease-specific DMCGs of palliative care |
||
|
DCCC Timely Detection |
||
|
Predicting Prostate Cancer by Liquid Biopsy |
||
|
Personalised Preventive Colorectal Cancer Medicine |
||
|
IMPROVE IT – preventive chemotherapy for patients with circulating tumor DNA in the blood after operation |
||
|
ALASCCA - (Adjuvant Low dose ASpirin in Colorectal CAncer) |
||
|
DATHYRCA |
||
|
Danish Neuroendocrine Tumor Company, DANETS |
||
|
Prognostic value of coronary calcium score and statin treatment of irradiated patients with locally advanced lung- and esophageal cancer |
||
|
DCCC Patient Reported Outcome (DCCC PRO) |
||
|
DCCC – DAnish OncoGEriatical Network (AGE) |
||
|
Implementation of online monitoring in brachytherapy for increased patient safety in treatments |
||
|
Model-bases selection of patients for advanced cancer therapies |
||
|
Taste of life - network on head and neck cancer with focus on the |
||
|
Danish study of personalized cancer therapy based on tumor genetics |
||
|
The Wait and Watch 3 trial: Randomized trial of standard dose versus high dose of radiotherapy in rectal preservation with chemo-radiotherapy to patients with low and mid rectal cancer. |
||
|
National Database for Metastatic Breast Cancer |
||
|
DCCC Danish circulating tumor DNA network (DCCC ctDNA) |
||
|
Workshops for generation of organ at risk contours for national automatic contouring atlas |
||
|
Danish network of preclinical radiobiology research |
||
|
Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy in Patients with Early Breast Cancer |
||
|
National collaboration in immunoradiotherapy |
||
|
The DMCG HPV Squamous Cell Carcinoma National Cohort Project |
||
|
IMPROVE‐IT2 |
||
|
Breast cancer: Scientific seminar on neoadjuvant chemotherapy |
||
|
A national strategy for MR accelerator based radiotherapy |
||
|
National Research Network on Nutrition in Cancer (NARNUCA) |
||
|
National network for diagnostics and follow-up of defect mismatch repair |
||
|
Developing and testing a new tool for measuring self-efficacy inintestinal stoma care – A Danish multicenter study |
||
|
Danish Thymoma Interest Group |
||
|
The NAVIGATE trial: Improved treatment adherence in socially vulnerable lung cancer patients |
||
|
National workshops for knowledge sharing and further development of radiation therapy quality assurance for clinical trials and clinical practice |
||
|
Implementation of clinical cancer guidelines – from paper to patient |
||
|
National workshop for the optimisation and homogenisation of target delineation in head and neck cancer radiotherapy |
||
|
Multidisciplinary Team Conferences in cancer care: Consistency in treatment recommendations in Ovarian Cancer |
||
|
Quality of Life and follow-up after esophageal and stomach cancer surgery |
||
|
Barriers affecting equality in clinical trial participation and use of proton therapy for Danish patients with head and neck cancer |
||
|
The Danish National Head and Neck Cancer Day |
||
|
Multidisciplinary Network for Focal Therapy of Prostate Cancer |
||
|
NOAC 9 - A Phase III Randomized Nordic Anal Cancer Group Study on Circulating Tumor DNA guided Follow-Up |
||
|
'No one should be left alone with late adverse effect after cancer treatment' - popular science |
||
|
Danish Research Center for Cancer and Obesity (Obe-CaRe) |
||
|
Diffusion tensor imaging (DTI) for RT target definition and dose escalation in glioblastoma (GBM) |
||
|
A Danish Nationwide Phase II Trial on HER2 targeted Therapy in Combination with Physicians Choice Chemotherapy for Patients with HER2 positive Esophageal Squamous Cell Carcinoma |
||
|
CAR T-cell therapy combined with radiotherapy as bridging for patients with R/R aggressive B-cell malignancies |
||
|
CIRCPAC: Implementing non-invasive circulating tumour DNA and circular DNA analysis in patients with local pancreatic cancer to optimize the pre- and postoperative treatment: predicting resectability and recurrence and changing prognosis over time. |
||
|
The future cancer screening programmes |
||
|
Whole Body – MRI in Colon Cancer |
||
|
PROton versus Photon Therapy – A randomized controlled trial for local/locally advanced PROstate cancer (PRO-PROstate1) |
||
|
National Quality Assurance program for radiotherapy delineation in brain cancer patients |
||
|
Circulating tumor DNA for the proper allocation of completion resection in early colorectal cancer |
||
|
DANERA: External radiation therapy in neuroendocrine neoplasms: A nationwide Danish prospective study |
||
|
Venous thromboembolism in patients diagnosed with primary lung cancer with a special focus on improved treatment and quality of life for the individual patient |
||
|
Multidisciplinary network for proton therapy for high-risk prostate cancer in a randomised phase III trial |
||
|
Patient involvement in therapy of breast cancer patients according to the DBCG guidelines |
||
|
Implementation of individualized treatment in patients with glioblastoma in a phase I / II clinical trial based on clonal mutations |
||
|
Post radiotherapy swallowing dysfunction and impact on quality of life (QoL) in patients with Head and Neck cancer. Rehabilitative swallowing interventions for the treatment of radiated induced dysphagia after head and neck cancer |
||
|
Personalised radiotherapy for optimised glioblastoma treatment |
||
|
Radiation-induced diarrhoea in pelvic cancer during curative external radiotherapy: The role of nutritional treatment |
||
|
A phase 3 study of reduced-dose combination chemotherapy versus standard monotherapy (Gemcitabine) in elderly and/or fragile patients with inoperable pancreatic cancer (DPCG-01) |
||
|
Proton therapy of fragile non-small cell lung cancer patients |
||
|
National, interdisciplinary network for research in cancer associated thrombosis |
||
|
CDK4/6 inhibitors beyond progression in metastatic breast cancer |
||
|
National Network for Obesity and Cancer Research (ObeCaRe) |
||
|
COMPARE - cancer pain module in PainData |
||
|
Neoadjuvant immunotherapy in dMMR colorectal cancer |
||
|
The FRAGINOC study: The impact of FRAilty screening, Geriatric assessment and INtervention in older patients with epithelial Ovarian Cancer |
||
|
Prehabilitation of frail patients before cancer surgery |
||
|
Frailty and the effect of perioperative Comprehensive Geriatric Assesment in older patients with muscle invasive bladder cancer and sheduled radical cystectomy |
||
|
The OLIGO project – A platform for an oligometastatic treatment strategy |
||
|
Danish CAR-T cell Network (DCTN) |
||
|
Centre for Cancer-related Additive Manufacturing in Danish Hospitals - CCAMDH |
||
|
Network for health care professionals occupied in Danish cancer sequelae clinics |
||
|
Glioblastoma: Using proteomics to search for biomarkers before and after oncological treament |
||
|
Dual-energy CT in preparation of radiotherapy for cancer patients |
||
|
Urothelial Bladder Cancer Intervention Study Based On Molecular Tumour Markers (Ultimate) |
||
|
Quality of life in Danish multiple myeloma patients |
||
|
MONITOR - Monitoring treatment response in metastatic breast cancer: a multicenter randomized controlled trial comparing FDGPET/ CT with conventional CT |
||
|
Initiation of a prospective, multi-center cohort study ’DBCG CLEVERER - local ablative therapy in de novo oligometastatic breast cancer’ |
||
|
Colorectal cancer patients’ perceived barriers and facilitators for returning to work |
||
|
Peri-operative treatment with Tranexamic Acid in melanoma; prognostic and treatment related impact of the plasminogen-plasmin pathway |
||
|
Annual workshops in Network for harmonization of somatic variant interpretation for treatment purposes for patients with treatment refractory cancer (DCCC no. 19) |
||
| Project and network |
National and multidisciplinary network on venous thromboembolism in esophagogastric cancer |
|
| Projects and Network |
RIPEC - Repeated intraperitoneal Chemotherapy. Improving survival and QoL for patients with moderate to severe peritoneal carcinomatosis from gastric- and GEJ cancer |
|
| Projects and Networks |
Establishment of a National Advisory Board on Cancer in Pregnancy |
|
| Projects and Network |
Surgical Innovation and Advanced Techniques in Cancer Surgery and a national platform for experimental cancer surgery – A National Network |
|
|
ctDNA Response Evaluation Criteria in Solid Tumors - ctDNA-RECIST Phase I |
||
|
Regional differences in the survival of ovarian Cancer patients in Denmark causes and solutions |
||
|
Disseminating knowledge about obesity and cancer across the country - via ObeCaRe |
||
|
Danish Psycho-Oncology Coorporative group (DPOC) |
||
|
Artificial intelligence in radiotherapy on a national scale |
||
|
RESPONSE: Colorectal cancer survivors’ follow-up care – now digital and need-based. A national interventional eff ectiveness trial for stage I and II patients |
||
|
DECIDE – [DE]termining [C]T scans with [I]ndeterminate fi ndings by circulating tumor [D]NA [E]valuation |
||
|
The REBECCA intervention to improve treatment adherence and symptoms in socially and psychologically vulnerable breast cancer patients |
||
|
Molecularly tailored therapy versus standard of care as second-line therapy in patients with pancreatic cancer, a randomized, nationwide DPCG trial (DPCG-02) |
||
|
Beyond surgery for cancer - how to innovate the follow-up programs and improve survivorship – A National Network |
||
|
A nationwide database for patients treated with CART therapies |
||
|
PANTHEON – a peripheral T-cell lymphoma master trial |
